Screening for PanIN or IPMN is especially important in people with familial pancreatic cancer, Peutz-Jeghers syndrome, familial atypical multiple mole melanoma syndrome, and genetic mutations like PALB2 or BRCA29. This evidence concerns the gene PALB2 and pancreatic intraductal papillary-mucinous neoplasm.